Signos, a startup that aims to help people lose weight by understanding their blood sugar, has raised a new $20 million round of funding as it looks beyond its direct-to-consumer roots to employers, health insurers and pharma companies.
Signos, a startup that aims to help people lose weight by understanding their blood sugar, raised $20 million as it looks beyond its direct-to-consumer roots …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device…
Google Ventures, Dexcom, and Blue Cross Blue Shield of Alabama backed the round as demand for weight loss tools grows
Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from…
Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs
Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose
La jeune pousse a vu ses abonnés et ses revenus exploser. Mais son modèle, basé sur le contrôle du glucose, inquiète des…
